Skip to content

Sedasys Post Approval Study Users Response to System Alarms

Open-Label Post Approval Study of the SEDASYS System User Response to System Alarms

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02573818
Enrollment
51
Registered
2015-10-12
Start date
2015-09-01
Completion date
2016-06-15
Last updated
2017-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conscious Sedation

Keywords

sedation for EGD and colonoscopy procedures

Brief summary

The purpose of this study is to evaluate the users' responses to the SEDASYS® System alarms during esophagogastroduodenoscopy (EGD) or colonoscopy.

Interventions

DEVICESEDASYS System

propofol sedation with the SEDASYS System

Sponsors

Ethicon Endo-Surgery
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists (ASA) I and II * male and female * Scheduled for routine colonoscopy or EGD * ≥18 years of age * Able to read, speak, and understand English

Exclusion criteria

* Physical or psychological condition which would impair trial participation, at the discretion of the PI * BMI ≥ 35 * Pregnancy or lactation * Known or suspected hypersensitivity to propofol or fentanyl * Use of a fentanyl patch * Allergies to eggs, egg products soybeans or soy products * Diagnosis of sleep apnea * Gastroparesis * Full stomach at the time of procedure * Participation in any other investigational device or drug study within 30 days of enrollment

Design outcomes

Primary

MeasureTime frame
Percent of documented responses/actions taken in response to SEDASYS System alarms (oxygen desaturation, apnea, hypotension, and bradycardia alarms)<24 hours, i.e., for duration of study procedure

Secondary

MeasureTime frame
Fraction of users responses/actions to oxygen desaturation, apnea, hypotension, and/or bradycardia alarms deemed sufficient by Endpoint Adjudication Committee (EAC)assessment of sufficient alarms will be reviewed by EAC after 100, 400, and 866 subjects completed the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026